Verastem (VSTM) Notes Payables (2022 - 2026)
Verastem (VSTM) recorded quarterly Notes Payables of $529000.0 in Q1 2026, up 181.38% quarter-over-quarter from $188000.0 in Q3 2025, and down 28.51% on a YoY basis from $740000.0 in Q1 2025.
Verastem (VSTM) Notes Payables (2022 - 2026) Analysis & Trends
Verastem's Notes Payables history runs 5 years deep, the most recent figure standing at $529000.0 for Q1 2026.
- In Q1 2026, Notes Payables fell 28.51% year-over-year to $529000.0; the TTM figure through Mar 2026 stood at $529000.0 (down 28.51% YoY), while the FY2022 annual figure was $275000.0, changed N/A from the prior year.
- Notes Payables was $529000.0 for Q1 2026 at Verastem, up from $188000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $1.0 million in Q1 2023 to a low of $133000.0 in Q3 2024.
- Historically, Notes Payables has averaged $499818.2 across 5 years, with a median of $526000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Notes Payables jumped 41.35% in 2025, then fell 28.51% in 2026.
- A 5-year view of Notes Payables shows it stood at $275000.0 in 2022, then slumped by 46.91% to $146000.0 in 2023, then slipped by 8.9% to $133000.0 in 2024, then surged by 41.35% to $188000.0 in 2025, then jumped by 181.38% to $529000.0 in 2026.
- The last three Notes Payables figures came in at $529000.0 (Q1 2026), $188000.0 (Q3 2025), and $467000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 529,000.00 |
| Sep 30, 2025 | 188,000.00 |
| Jun 30, 2025 | 467,000.00 |
| Mar 31, 2025 | 740,000.00 |
| Sep 30, 2024 | 133,000.00 |
| Jun 30, 2024 | 526,000.00 |
| Mar 31, 2024 | 911,000.00 |
| Sep 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 579,000.00 |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 275,000.00 |